Evidence map›Paper›PMID 33139981›Full record

ArticleIntractable & rare diseases research2020

Two new missense mutations in the protein interaction ASH domain of OCRL1 identified in patients with Lowe syndrome.

Ana Perdomo-Ramirez, Montserrat Antón-Gamero, Daniela Sakaguchi Rizzo, Amelia Trindade, Elena Ramos-Trujillo, Felix Claverie-Martin

Open access · diamondAbstract read
In one paragraph

Article in Intractable & rare diseases research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ana Perdomo-RamirezUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Montserrat Antón-GameroNefrología Pediátrica, Hospital Universitario Reina Sofía, Córdoba, Spain.
Daniela Sakaguchi RizzoMedical Center, Sao Carlos, Sao Paulo, Brazil.
Amelia TrindadeDepartamento de Medicina, Universidade Federal de Sao Carlos, Sao Paulo, Brazil.
Elena Ramos-TrujilloUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Felix Claverie-MartinUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Hospital Universitario Nuestra Señora de Candelaria · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oculocerebrorenal syndrome of Lowe is a rare X-linked disease characterized by congenital cataracts, proximal renal tubulopathy, muscular hypotonia and mental impairment. This disease is caused by mutations in the

Indexed as

ASH domainLowe syndromemissense mutationOCRL

Identifiers

PMID33139981
PMCPMC7586875
OpenAlexW3092571185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.